Nature’s recent interview with our Founder & CSO, Dr. Marcelo Hill
ARDAN PHARMA is thrilled to announce its participation at the semifinalist stage of the 2021 Women’s Venture Competition – AIM-HI Accelerator.
by i2medialab Policies
ARDAN PHARMA maintains and discloses a written policy on financial conflict of interest which is consistent with 42 CFR. 50.
by i2medialab Blood
Blood. (2021) July 22, Vol.138, (3), 246-258. “AID overexpression leads to aggressive murine CLL and non immunoglobulin mutations that mirror human neoplasms”
by i2medialab ARDAN PHARMA is semifinalist in AIM-HI Accelerator Competition
ARDAN PHARMA is thrilled to announce its participation at the semifinalist stage of the 2021 Women’s Venture Competition – AIM-HI Accelerator.
by i2medialab